Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryan P White

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Jac-Antimicrobial Resistance|February 16, 2026
Longitudinal trends in community-onset bacteraemia caused by ceftriaxone non-susceptible <i>Escherichia coli, Proteus mirabilis, Klebsiella oxytoca</i>, and <i>Klebsiella pneumoniae</i> (2016-2024)Raveena Patel, Laura G Stoudenmire, Cong Cheng, et al.
Plos One|January 12, 2013
Evaluating ethanol-based sample preservation to facilitate use of DNA barcoding in routine freshwater biomonitoring programs using benthic macroinvertebratesEric D Stein, Bryan P White, Raphael D Mazor, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|September 28, 2022
Impact of suppressing ciprofloxacin susceptibility results on antibiotic utilization and hospital-acquired <i>Clostridioides difficile</i> infectionBryan P White, Daniel B Chastain, Karen K Kinney, et al.
The Annals of Pharmacotherapy|March 22, 2023
Therapeutic Options for Adult Patients With Persistent Methicillin-Susceptible <i>Staphylococcus aureus</i> Bacteremia: A Narrative ReviewDaniel B Chastain, Kelly L Covert, Patrick J Tu, et al.
The Annals of Pharmacotherapy|December 7, 2024
Pivmecillinam for Uncomplicated Acute Cystitis: A Contemporary ReviewJessica E Burchette, Kelly Covert, Patrick Tu, et al.
Journal of the Pediatric Infectious Diseases Society|April 7, 2022
Impact of Ceftazidime Use on Susceptibility Patterns in a Neonatal Intensive Care Unit: A 7.5-year EvaluationRebecca A Mayes, Peter N Johnson, Bryan P White, et al.
Jac-Antimicrobial Resistance|September 11, 2024
Risk factors for positive follow-up blood cultures in critically ill adults with Gram-negative bacteraemiaRebecca A Mayes, Emily A Siegrist, Julia Mathew, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|August 6, 2025
Incidence and risk factors for musculoskeletal adverse effects associated with daptomycin in patients receiving outpatient parenteral antimicrobial therapyMeaghen B Wiley, Kiya K Bennett, Emily A Siegrist, et al.
The Annals of Pharmacotherapy|April 29, 2022
Evaluation of Ceftazidime Use in the Neonatal Intensive Care Unit and Association With Cephalosporin-Resistant Gram-Negative BacteriaRebecca A Mayes, Peter N Johnson, Bryan P White, et al.
Journal of Pharmacy Practice|April 15, 2024
CNS Aspergillosis and Cryptococcosis with Cytomegalovirus Pneumonia in a Patient with Chronic Lymphocytic Leukemia Treated with AcalabrutinibTaylor Fallin, Erica Thacker, Syeda Sahra, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Jac-Antimicrobial Resistance|February 16, 2026
Longitudinal trends in community-onset bacteraemia caused by ceftriaxone non-susceptible <i>Escherichia coli, Proteus mirabilis, Klebsiella oxytoca</i>, and <i>Klebsiella pneumoniae</i> (2016-2024)Raveena Patel, Laura G Stoudenmire, Cong Cheng, et al.
Plos One|January 12, 2013
Evaluating ethanol-based sample preservation to facilitate use of DNA barcoding in routine freshwater biomonitoring programs using benthic macroinvertebratesEric D Stein, Bryan P White, Raphael D Mazor, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|September 28, 2022
Impact of suppressing ciprofloxacin susceptibility results on antibiotic utilization and hospital-acquired <i>Clostridioides difficile</i> infectionBryan P White, Daniel B Chastain, Karen K Kinney, et al.
The Annals of Pharmacotherapy|March 22, 2023
Therapeutic Options for Adult Patients With Persistent Methicillin-Susceptible <i>Staphylococcus aureus</i> Bacteremia: A Narrative ReviewDaniel B Chastain, Kelly L Covert, Patrick J Tu, et al.
The Annals of Pharmacotherapy|December 7, 2024
Pivmecillinam for Uncomplicated Acute Cystitis: A Contemporary ReviewJessica E Burchette, Kelly Covert, Patrick Tu, et al.
Journal of the Pediatric Infectious Diseases Society|April 7, 2022
Impact of Ceftazidime Use on Susceptibility Patterns in a Neonatal Intensive Care Unit: A 7.5-year EvaluationRebecca A Mayes, Peter N Johnson, Bryan P White, et al.
Jac-Antimicrobial Resistance|September 11, 2024
Risk factors for positive follow-up blood cultures in critically ill adults with Gram-negative bacteraemiaRebecca A Mayes, Emily A Siegrist, Julia Mathew, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|August 6, 2025
Incidence and risk factors for musculoskeletal adverse effects associated with daptomycin in patients receiving outpatient parenteral antimicrobial therapyMeaghen B Wiley, Kiya K Bennett, Emily A Siegrist, et al.
The Annals of Pharmacotherapy|April 29, 2022
Evaluation of Ceftazidime Use in the Neonatal Intensive Care Unit and Association With Cephalosporin-Resistant Gram-Negative BacteriaRebecca A Mayes, Peter N Johnson, Bryan P White, et al.
Journal of Pharmacy Practice|April 15, 2024
CNS Aspergillosis and Cryptococcosis with Cytomegalovirus Pneumonia in a Patient with Chronic Lymphocytic Leukemia Treated with AcalabrutinibTaylor Fallin, Erica Thacker, Syeda Sahra, et al.
Pageof 5